HTGM Htg Molecular Diagnostics Inc

HTG Molecular Diagnostics Inc is a commercial stage company. It develops & markets a novel technology platform to facilitate the routine use of complex molecular profiling with its focus on clinical applications.

$3.23  -0.27 (-7.71%)
As of 12/06/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  05/06/2015
Outstanding shares:  7,567,759
Average volume:  42,121
Market cap:   $26,487,157
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    40434H203
ISIN:        US40434H2031
Valuation   (See tab for details)
PE ratio:   -1.50
PB ratio:   2.15
PS ratio:   3.08
Return on equity:   -109.11%
Net income %:   -188.60%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy